Focused Large Cap Value Fund
Daily price w/o sales charge as of 03/21/2025
$13.18
$0.04
YTD Returns w/o sales charge as of 03/21/2025
0.69%
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 02/28/2025
- Total Net Assets
- $35.64 M
- Inception Date
- 08/01/2019
- Dividend Frequency
- Annually
- Fund Gross Expense Ratio
- 1.64%
- Fund Net Expense Ratio
- 0.96%
- Number of Holdings
- 28
- Minimum Initial Investment
- $1,500+
Fund Expense Ratio :
Gross 1.64%
Net 0.96%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/31/2019 |
---|
w/o sales charge | 4.43% | 17.42% | 9.30% | 15.13% | - | 11.27% |
Lipper Category Avg. Multi-Cap Value Funds | 4.19% | 14.33% | 8.33% | 13.22% | - | - |
Russell 1000® Value Index | 5.05% | 15.75% | 8.65% | 12.51% | - | 10.21% |
w/ sales charge | -1.58% | 10.71% | 7.16% | 13.77% | - | 10.09% |
Fund Expense Ratio :
Gross 1.64%
Net 0.96%
Fund Expense Ratio :
Gross 1.64%
Net 0.96%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/31/2019 |
---|
w/o sales charge | 21.00% | 21.00% | 7.36% | 10.59% | - | 10.74% |
Lipper Category Avg. Multi-Cap Value Funds | 13.68% | 13.68% | 6.14% | 9.35% | - | - |
Russell 1000® Value Index | 14.37% | 14.37% | 5.63% | 8.68% | - | 9.53% |
w/ sales charge | 14.07% | 14.07% | 5.26% | 9.28% | - | 9.53% |
Fund Expense Ratio :
Gross 1.64%
Net 0.96%
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 02/28/2025
Holding | Assets |
---|---|
JPMorgan Chase & Co | 4.9% |
Aon PLC | 4.8% |
Fiserv Inc | 4.5% |
Charles Schwab Corp/The | 4.3% |
AbbVie Inc | 4.1% |
Gilead Sciences Inc | 4.1% |
Alphabet Inc | 3.9% |
RTX Corp | 3.9% |
TD SYNNEX Corp | 3.7% |
Labcorp Holdings Inc | 3.7% |
Sector Allocationas of 02/28/2025
Sector | Weighting | Fund Change from Previous Quarter |
---|
Sector | Weighting | Fund Change from Previous Quarter |
---|---|---|
Communication Services |
![]() |
|
Real Estate |
![]() |
|
Utilities | 0.0% | |
Consumer Discretionary |
![]() |
|
Consumer Staples | 0.0% | |
Energy |
![]() |
|
Financials |
![]() |
|
Health Care |
![]() |
|
Industrials |
![]() |
|
Information Technology |
![]() |
|
Materials | 0.0% |
INVESTMENT TEAM



Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
Gross 1.64%
Net 0.96%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/31/2019 |
---|
w/o sales charge | 4.43% | 17.42% | 9.30% | 15.13% | - | 11.27% |
Lipper Category Avg. Multi-Cap Value Funds | 4.19% | 14.33% | 8.33% | 13.22% | - | - |
Russell 1000® Value Index | 5.05% | 15.75% | 8.65% | 12.51% | - | 10.21% |
w/ sales charge | -1.58% | 10.71% | 7.16% | 13.77% | - | 10.09% |
Fund Expense Ratio :
Gross 1.64%
Net 0.96%
Fund Expense Ratio :
Gross 1.64%
Net 0.96%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/31/2019 |
---|
w/o sales charge | 21.00% | 21.00% | 7.36% | 10.59% | - | 10.74% |
Lipper Category Avg. Multi-Cap Value Funds | 13.68% | 13.68% | 6.14% | 9.35% | - | - |
Russell 1000® Value Index | 14.37% | 14.37% | 5.63% | 8.68% | - | 9.53% |
w/ sales charge | 14.07% | 14.07% | 5.26% | 9.28% | - | 9.53% |
Fund Expense Ratio :
Gross 1.64%
Net 0.96%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
The Fund changed its investment strategy on 07/31/2019. Performance is calculated from this date.
Year | Fund Returns | Russell 1000® Value Index |
---|
2024 | 21.00% | 14.37% |
2023 | 14.06% | 11.46% |
2022 | -10.35% | -7.54% |
2021 | 27.77% | 25.16% |
2020 | 4.61% | 2.80% |
Year | Q1 | Q2 | Q3 | Q4 |
---|
2025 | - | - | - | - |
2024 | 13.24% | -1.12% | 7.45% | 0.58% |
2023 | -0.93% | 3.86% | -1.41% | 12.44% |
2022 | -1.56% | -13.47% | -7.02% | 13.21% |
2021 | 14.47% | 4.99% | -0.38% | 6.72% |
2020 | -36.16% | 28.97% | 2.09% | 24.45% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
NAV HISTORICAL PRICES
Date | Net Asset Value |
---|
Portfolio
Portfolio
Holding | Sector | Assets |
---|
JPMorgan Chase & Co | Financials | 4.9% |
Aon PLC | Financials | 4.8% |
Fiserv Inc | Financials | 4.5% |
Charles Schwab Corp/The | Financials | 4.3% |
AbbVie Inc | Health Care | 4.1% |
Gilead Sciences Inc | Health Care | 4.1% |
Alphabet Inc | Communication Services | 3.9% |
RTX Corp | Industrials | 3.9% |
TD SYNNEX Corp | Information Technology | 3.7% |
Labcorp Holdings Inc | Health Care | 3.7% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Holding | Sector | Assets |
---|
JPMorgan Chase & Co | Financials | 5.1% |
Charles Schwab Corp/The | Financials | 4.5% |
Alphabet Inc | Communication Services | 4.4% |
Fiserv Inc | Financials | 4.3% |
Aon PLC | Financials | 4.2% |
KKR & Co Inc | Financials | 3.9% |
TD SYNNEX Corp | Information Technology | 3.8% |
Taiwan Semiconductor Manufacturing Co Ltd | Information Technology | 3.8% |
Parker-Hannifin Corp | Industrials | 3.8% |
RTX Corp | Industrials | 3.7% |
Cummins Inc | Industrials | 3.6% |
Labcorp Holdings Inc | Health Care | 3.5% |
BJ's Wholesale Club Holdings Inc | Consumer Staples | 3.5% |
CRH PLC | Materials | 3.5% |
Allegion plc | Industrials | 3.4% |
AbbVie Inc | Health Care | 3.4% |
CBRE Group Inc | Real Estate | 3.3% |
Microsoft Corp | Information Technology | 3.3% |
AerCap Holdings NV | Industrials | 3.2% |
RenaissanceRe Holdings Ltd | Financials | 3.2% |
Lowe's Cos Inc | Consumer Discretionary | 3.0% |
Merck & Co Inc | Health Care | 2.8% |
Target Corp | Consumer Staples | 2.8% |
NetApp Inc | Information Technology | 2.7% |
Shell PLC | Energy | 2.7% |
Gilead Sciences Inc | Health Care | 2.5% |
Expand Energy Corp | Energy | 2.5% |
Best Buy Co Inc | Consumer Discretionary | 2.4% |
Diamondback Energy Inc | Energy | 2.4% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 02/28/2025
Sector | Weighting | Fund Change from Previous Quarter |
---|
Sector | Weighting | Fund Change from Previous Quarter |
---|---|---|
Communication Services |
![]() |
|
Real Estate |
![]() |
|
Utilities | 0.0% | |
Consumer Discretionary |
![]() |
|
Consumer Staples | 0.0% | |
Energy |
![]() |
|
Financials |
![]() |
|
Health Care |
![]() |
|
Industrials |
![]() |
|
Information Technology |
![]() |
|
Materials | 0.0% |
PORTFOLIO DETAILS as of 02/28/2025
- Total Net Assets
- $35.64 M
- Number of Holdings
- 28
- Weighted Average Market Cap.
- 329.2 B
- P/B Ratio
- 3.3x
- P/E Ratio
- 20.6x
To view definitions for the above Portfolio Details, Click here.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Portfolio Turnover - This is a measure of the Fund’s trading activity which is computed by taking the lesser of purchases or sales divided by average monthly market value, excluding short-term investments. The resulting percentage represents the percentage of the portfolio’s holdings that have changed over the past year.
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 03/21/2025
Sales Charge | Dealer's Concession | Prices at Breakpoint | |
---|---|---|---|
Less than $50,000 | 5.75% | 5.00% | $13.98 |
$50,000 to $99,999 | 4.75% | 4.00% | $13.84 |
$100,000 to $249,999 | 3.95% | 3.25% | $13.72 |
$250,000 to $499,999 | 2.75% | 2.25% | $13.55 |
$500,000 to $999,999 | 1.95% | 1.75% | $13.44 |
$1,000,000 to $5,000,000 | 0.00% | 1.00% | $13.18 |
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratio
Fund Gross Expense Ratio | Fund Net Expense Ratio | |
---|---|---|
1.64% | 0.96% |
Expense ratio details, Click here.
The net expense ratio takes into account contractual fee waivers/expense reimbursements that currently are scheduled to remain in place through 02/28/2026. For periods when fees and expenses were waived and/or reimbursed, the Fund benefited by not bearing such expenses. Without such fee waivers/reimbursements, performance would have been lower.
Fund Documents
Fund Documents
0Documents selected
|
||||
---|---|---|---|---|
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
Summary Prospectus
Publish Date:11/03/2015
|
||||
Statutory Prospectus
Publish Date:11/03/2015
|
||||
SAI
Publish Date:11/03/2015
|
||||
Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
Semi-Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
Fact Sheet
Publish Date:11/03/2015
|